Zydus Lifesciences has informed that it enclosed a copy of press release dated November 6, 2023 titled ‘Zydus receives USFDA approval for ZITUVIMETTM to treat adult patients with type 2 diabetes mellitus’.
The above information is a part of company’s filings submitted to BSE.